Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register
Degarelix acetate bulk supplier for pharma manufacturers

Degarelix Acetate 120 mg/vial, 80 mg/vial Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 120 mg/vial, 80 mg/vial

Reference Brands: Firmagon (USA, EU)

Category: Oncology Cancer Care

Degarelix acetate is a gonadotropin-releasing hormone (GnRH) receptor antagonist used in the treatment of advanced prostate cancer. It rapidly reduces testosterone levels without the initial surge seen with LHRH agonists.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Degarelix Acetate? List it or send an offer →

Product Description:

Degarelix blocks the GnRH receptor in the pituitary directly, as an antagonist. That mechanism matters because the older LHRH agonists first stimulate the receptor before downregulating it, producing a testosterone surge in the opening fortnight that can worsen bone pain, urinary obstruction or spinal cord compression in men with heavy disease. Degarelix suppresses testosterone to castrate levels within three days with no flare and therefore no need for antiandrogen cover.

It is used for advanced hormone-dependent prostate cancer, given as a monthly subcutaneous depot into the abdominal wall. The first dose is a 240 mg loading dose administered as two 120 mg injections, followed by 80 mg monthly. Injection site reactions — pain, erythema and induration — are common with the loading dose and diminish thereafter. Hot flushes, weight gain, raised transaminases and the metabolic and bone consequences of androgen deprivation follow the class.

Sourcing notes. Originator product; patents have begun to lapse and generic entry is emerging in some markets. The two vial strengths serve different phases of treatment, so a quotation must account for two 120 mg vials in cycle one. Powder for reconstitution, room temperature, used immediately after mixing.

Degarelix Acetate — third party manufacturing & bulk supply

Degarelix Acetate 120 mg/vial, 80 mg/vial is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.
Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.
Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Degarelix Acetate is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Degarelix Acetate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Degarelix Acetate →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Degarelix acetate is used to treat advanced prostate cancer in men. It works by blocking the action of gonadotropin-releasing hormone (GnRH), leading to a rapid decrease in testosterone levels, which helps slow or stop the growth of prostate cancer cells that depend on testosterone.

Degarelix acetate is made from degarelix, a synthetic decapeptide that acts as a GnRH receptor antagonist. It is formulated as a lyophilized powder that is reconstituted with sterile water before subcutaneous injection. Excipients may include mannitol and other stabilizers.

The most common trade name for Degarelix acetate is Firmagon.

Degarelix acetate (Firmagon) is manufactured by Ferring Pharmaceuticals. Several generic manufacturers also produce it under different brand names in various regions.

The generic name is degarelix acetate.

The brand name is Firmagon.

Degarelix acetate is manufactured by Ferring Pharmaceuticals in Switzerland and other authorized production facilities in Europe. It is also produced by licensed generic manufacturers in India for international export.

Related Products

Tivozanib Hydrochloride

Strength:
0.89 mg, 1.34 mg

Form: Capsules

Reference Brands: Fotivda (USA/EU)

View Details
Fruquintinib Hydrochloride

Strength:
1 mg, 5 mg

Form: Capsules

Reference Brands: Fruzaqla (USA/EU), Elunate (USA/EU)

View Details
Exemestane

Strength:
25 mg

Form: Tablets

Reference Brands: Aromasin (USA/EU)

View Details
Pralsetinib

Strength:
100 mg

Form: Capsules

Reference Brands: Gavreto (USA/EU)

View Details
Panobinostat Lactate

Strength:
10 mg, 15 mg, 20 mg

Form: Capsules

Reference Brands: Farydak (USA/EU),

View Details
Vorinostat

Strength:
100 mg

Form: Capsules

Reference Brands: Zolinza (USA/EU), Vornat (India)

View Details
Fruquin 5 Mg (Fruquintinib)

Strength:
5 Mg

Form: Capsules

Reference Brands: Everest Bangladesh altd.

View Details
Vepdegestrant Tablets

Strength:
100 mg, 200 mg

Form: Tablets

Reference Brands: Veppanu (Arvinas)

View Details
Enquire Now

Usually answered within 48 hours | GMP documents shared before you commit

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us